Latest News about JNJ
Recent news which mentions JNJ
3 Dividend Stocks That Should Pay You for the Rest of Your Life
December 26, 2022
From Motley Fool
Why You Should Buy This Undervalued Stock Before Everyone Else Does
December 26, 2022
From Motley Fool
Barron's Top Weekend Stock Picks: Costco, Johnson & Johnson, And How Tesla Could Become A Value Stock
December 24, 2022
From Benzinga
2 Market-Beating Stocks to Buy in 2023 and Hold Forever
December 24, 2022
From Motley Fool
What the end of the stock market’s ‘FANG-era’ means for ETFs
December 22, 2022
From MarketWatch
Got $10,000? Here's How Much You Can Earn In Dividends -- Without Putting Your Portfolio at Risk
December 22, 2022
From Motley Fool
Will Investors Notice Exciting Sign On Johnson & Johnson's Chart?
December 21, 2022
Tickers
JNJ
From Benzinga
Interest Rate Hikes Won't Stop These 2 Cash-Rich Growth Stocks
December 21, 2022
From Motley Fool
The Best Stocks to Invest $20,000 in Right Now
December 21, 2022
From Motley Fool
2 Mammoth Stocks With Dividends to Buy Before 2022 Ends
December 21, 2022
From Motley Fool
Twitter Rolls Out 'Blue For Business,' Visa Pitches Auto-Payments On Ethereum Blockchain, Justin Bieber Slams H&M: Today's Top Stories
December 20, 2022
From Benzinga
From Benzinga
10 Top Dividend Stocks To Buy For 2023
December 20, 2022
From Motley Fool
2 Stocks to Buy Before 2023 and Hold Forever
December 20, 2022
From Motley Fool
Want $250 in Passive Income? Buy These 2 Dividend Kings and Wait
December 16, 2022
From Motley Fool
Warren Buffett Loves These Stocks. Should You Buy Them Before 2023?
December 16, 2022
From Motley Fool
5 Phenomenal Stocks in Warren Buffett's Secret Portfolio That Are Screaming Buys in 2023
December 16, 2022
From Motley Fool
From Benzinga
West Africa-Based Studies Show JNJ, Merck's Ebola Vaccines Provide Lasting Antibodies
December 15, 2022
From Benzinga
2 Top Dividend Kings to Buy for the Long Haul
December 14, 2022
From Motley Fool
The 7 Best Investment Funds to Navigate a Possible Recession
December 13, 2022
From InvestorPlace
Best stock picks for 2023: Here are Wall Street analysts’ most heavily favored choices
December 13, 2022
From MarketWatch
Reliable Passive Income: an Analysis on Dividend Kings
December 13, 2022
From Motley Fool
More Likely to 5X First: Johnson & Johnson vs. Vertex Pharmaceuticals
December 13, 2022
From Motley Fool
3 High-Yielding Dividend Stocks That Could Beat the Market in 2023
December 13, 2022
From Motley Fool
From MarketWatch
Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal
December 12, 2022
From InvestorPlace
2 Dividend Aristocrats to Buy and Hold Until You Retire
December 12, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.